Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants (vol 140, pg 337, 2022)-论文-万方医学网

首页> > Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants (vol 140, pg 337, 2022)

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants (vol 140, pg 337, 2022)

导出原文传递

翻译打印收藏纠错

第一作者： Hartnett, M. Elizabeth

作者： Hartnett, M. Elizabeth ; Wallace, David K. ; Dean, Trevano W. ; Li, Zhuokai ; Boente, Charline S. ; Dosunmu, Eniolami O. ; Freedman, Sharon F. ; Golden, Richard P. ; Kong, Lingkun ; Prakalapakorn, S. Grace ; Repka, Michael X. ; Smith, Lois E. ; Wang, Haibo ; Kraker, Raymond T. ; Cotter, Susan A. ; Holmes, Jonathan M. ; Pediat Eye Dis Investigator Grp

发布时间 2022-09-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants (vol 140, pg 337, 2022)

相似文献

同项目论文

相关期刊

检索历史 清除

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants (vol 140, pg 337, 2022)

相似文献

同项目论文

相关期刊

检索历史清除